Objective: To examine the pattern of mifepristone uptake in the United States and whether the introduction of this drug has facilitated access to abortion services.
Methods: Using data from a national census of abortion providers and from the U.S.
Background: This study measured differences in the provision of care between public and private providers of contraceptive services, what problems using contraception these providers perceived their patients to have and providers' views on how to improve their patients' method use.
Study Design: A nationally representative mixed-mode survey (mail, Internet and fax) of private family practice and obstetrician/gynecologist physicians who provided contraceptive care in 2005 was conducted. A parallel survey was administered to public contraceptive care providers in community health centers, hospitals, Planned Parenthood clinics and other sites during the same period.